Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 20 12 2018
accepted: 26 03 2019
revised: 06 03 2019
pubmed: 25 4 2019
medline: 27 8 2019
entrez: 25 4 2019
Statut: ppublish

Résumé

To develop and validate a proof-of-concept convolutional neural network (CNN)-based deep learning system (DLS) that classifies common hepatic lesions on multi-phasic MRI. A custom CNN was engineered by iteratively optimizing the network architecture and training cases, finally consisting of three convolutional layers with associated rectified linear units, two maximum pooling layers, and two fully connected layers. Four hundred ninety-four hepatic lesions with typical imaging features from six categories were utilized, divided into training (n = 434) and test (n = 60) sets. Established augmentation techniques were used to generate 43,400 training samples. An Adam optimizer was used for training. Monte Carlo cross-validation was performed. After model engineering was finalized, classification accuracy for the final CNN was compared with two board-certified radiologists on an identical unseen test set. The DLS demonstrated a 92% accuracy, a 92% sensitivity (Sn), and a 98% specificity (Sp). Test set performance in a single run of random unseen cases showed an average 90% Sn and 98% Sp. The average Sn/Sp on these same cases for radiologists was 82.5%/96.5%. Results showed a 90% Sn for classifying hepatocellular carcinoma (HCC) compared to 60%/70% for radiologists. For HCC classification, the true positive and false positive rates were 93.5% and 1.6%, respectively, with a receiver operating characteristic area under the curve of 0.992. Computation time per lesion was 5.6 ms. This preliminary deep learning study demonstrated feasibility for classifying lesions with typical imaging features from six common hepatic lesion types, motivating future studies with larger multi-institutional datasets and more complex imaging appearances. • Deep learning demonstrates high performance in the classification of liver lesions on volumetric multi-phasic MRI, showing potential as an eventual decision-support tool for radiologists. • Demonstrating a classification runtime of a few milliseconds per lesion, a deep learning system could be incorporated into the clinical workflow in a time-efficient manner.

Identifiants

pubmed: 31016442
doi: 10.1007/s00330-019-06205-9
pii: 10.1007/s00330-019-06205-9
pmc: PMC7251621
mid: NIHMS1588326
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Pagination

3338-3347

Subventions

Organisme : NCI NIH HHS
ID : R01 CA206180
Pays : United States
Organisme : RSNA Research and Education Foundation
ID : RR1731
Organisme : NCI NIH HHS
ID : NIH/NCI R01 CA206180
Pays : United States

Références

Radiology. 2018 Mar;286(3):887-896
pubmed: 29059036
Abdom Radiol (NY). 2016 May;41(5):963-9
pubmed: 27193793
Radiology. 2014 Dec;273(3):746-58
pubmed: 25028783
Acta Radiol. 2018 Feb;59(2):140-146
pubmed: 28648125
Biomed Mater Eng. 2015;26 Suppl 1:S1599-611
pubmed: 26405925
Hepatology. 2015 Mar;61(3):1056-65
pubmed: 25041904
Comput Biol Med. 2018 Mar 1;94:11-18
pubmed: 29353161
Gastroenterology. 2007 Jun;132(7):2557-76
pubmed: 17570226
Radiology. 2018 Jan;286(1):173-185
pubmed: 29091751
J Magn Reson Imaging. 2015 Aug;42(2):305-14
pubmed: 25371354
World J Radiol. 2010 Jun 28;2(6):215-23
pubmed: 21160633
Expert Rev Anticancer Ther. 2015 Feb;15(2):199-205
pubmed: 25371052
Med Phys. 2008 May;35(5):1734-46
pubmed: 18561648
Abdom Radiol (NY). 2018 Jan;43(1):231-236
pubmed: 29318354
Acad Radiol. 2016 Sep;23(9):1145-53
pubmed: 27174029
PLoS Med. 2018 Nov 20;15(11):e1002686
pubmed: 30457988
Radiology. 2014 Jul;272(1):132-42
pubmed: 24555636
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Brain. 2008 Nov;131(Pt 11):2969-74
pubmed: 18835868

Auteurs

Charlie A Hamm (CA)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Institute of Radiology, Humboldt-Universität, 10117, Berlin, Germany.

Clinton J Wang (CJ)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.

Lynn J Savic (LJ)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Institute of Radiology, Humboldt-Universität, 10117, Berlin, Germany.

Marc Ferrante (M)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.

Isabel Schobert (I)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Institute of Radiology, Humboldt-Universität, 10117, Berlin, Germany.

Todd Schlachter (T)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.

MingDe Lin (M)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.

James S Duncan (JS)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.
Department of Biomedical Engineering, Yale School of Engineering and Applied Science, New Haven, CT, 06520, USA.

Jeffrey C Weinreb (JC)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.

Julius Chapiro (J)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA. j.chapiro@googlemail.com.

Brian Letzen (B)

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH